Home > A. Molecular pathology > STRN3
STRN3
Monday 7 January 2019
| WKP |
Pathology
NTRK3 fusion genes in fibrosarcomas (30520818)
- NTRK fusions in malignant tumors are therapeutic targets of tyrosine kinase inhibitors.
- CD34-positive fibrosarcoma of bone and soft tissue could be a good candidate for NTRK testing.
- STRN1-NTRK3 and STRN3-NTRK fusion genes